Infrequent development of resistance in genotype 1-6 hepatitis c virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials
Evguenia S. Svarovskaia, Hadas Dvory Sobol, Neil Parkin, Christy Hebner, Viktoria Gontcharova, Ross Martin, Wen Ouyang, Bin Han, Simin Xu, Karin Ku, Sophia Chiu, Edward Gane, Ira M. Jacobson, David R. Nelson, Eric Lawitz, David L. Wyles, Neby Bekele, Diana Brainard, William T. Symonds, John G. McHutchisonMichael D. Miller, Hongmei Mo
Dive into the research topics of 'Infrequent development of resistance in genotype 1-6 hepatitis c virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials'. Together they form a unique fingerprint.